Effect of neoadjuvant chemotherapy on overall survival of patients with T2-4aN0M0 bladder cancer: A systematic review and meta-analysis according to EAU COVID-19 recommendation.
<h4>Purpose</h4>In the context of the COVID-19 outbreak, the European Association of Urology (EAU) guidelines Rapid Reaction Group provided recommendations to manage muscle invasive bladder cancer (MIBC) based on priority levels: neoadjuvant chemotherapy (NAC) should be avoided for patie...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0267410 |
| _version_ | 1811238871548035072 |
|---|---|
| author | Dong Hyuk Kang Kang Su Cho Young Joon Moon Doo Yong Chung Hae Do Jung Joo Yong Lee |
| author_facet | Dong Hyuk Kang Kang Su Cho Young Joon Moon Doo Yong Chung Hae Do Jung Joo Yong Lee |
| author_sort | Dong Hyuk Kang |
| collection | DOAJ |
| description | <h4>Purpose</h4>In the context of the COVID-19 outbreak, the European Association of Urology (EAU) guidelines Rapid Reaction Group provided recommendations to manage muscle invasive bladder cancer (MIBC) based on priority levels: neoadjuvant chemotherapy (NAC) should be avoided for patients with T2-3N0M0 MIBC. This meta-analysis aims to evaluate the efficacy of NAC compared with radical cystectomy (RC) alone in improving the overall survival (OS) of patients with T2-4aN0M0 MIBC.<h4>Materials and methods</h4>A systematic review was performed according to the PRISMA guidelines. The PubMed/Medline, EMBASE, and Cochrane Library databases were searched. The primary outcome was OS of patients with T2-4aN0M0 MIBC, and the secondary outcome was OS of patients with only T2N0M0 MIBC.<h4>Results</h4>Eight studies were included in this meta-analysis. Overall, the quality of all studies was relatively high, and little publication bias was demonstrated. The OS was significantly better in the NAC with RC group than in RC alone (HR, 0.79; 95% CI, 0.68-0.92; p = 0.002). A subgroup analysis was performed on only patients with T2N0M0 MIBC, and five studies were included. There was no difference in the OS between the NAC with RC and the RC alone groups (HR, 0.83; 95% CI, 0.69-1.01 p = 0.06).<h4>Conclusions</h4>As recommended by the EAU guidelines Rapid Reaction Group, patients with T2N0M0 MIBC should strongly consider omitting NAC until the end of the COVID-19 pandemic. Whether to omit NAC in T3-4aN0M0 MIBC needs further discussion, and studies targeting only T2-3N0M0 MIBC are expected to proceed further. |
| first_indexed | 2024-04-12T12:49:53Z |
| format | Article |
| id | doaj.art-c9ae2b5383894c15bdba39c49524e89a |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-12T12:49:53Z |
| publishDate | 2022-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-c9ae2b5383894c15bdba39c49524e89a2022-12-22T03:32:31ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01174e026741010.1371/journal.pone.0267410Effect of neoadjuvant chemotherapy on overall survival of patients with T2-4aN0M0 bladder cancer: A systematic review and meta-analysis according to EAU COVID-19 recommendation.Dong Hyuk KangKang Su ChoYoung Joon MoonDoo Yong ChungHae Do JungJoo Yong Lee<h4>Purpose</h4>In the context of the COVID-19 outbreak, the European Association of Urology (EAU) guidelines Rapid Reaction Group provided recommendations to manage muscle invasive bladder cancer (MIBC) based on priority levels: neoadjuvant chemotherapy (NAC) should be avoided for patients with T2-3N0M0 MIBC. This meta-analysis aims to evaluate the efficacy of NAC compared with radical cystectomy (RC) alone in improving the overall survival (OS) of patients with T2-4aN0M0 MIBC.<h4>Materials and methods</h4>A systematic review was performed according to the PRISMA guidelines. The PubMed/Medline, EMBASE, and Cochrane Library databases were searched. The primary outcome was OS of patients with T2-4aN0M0 MIBC, and the secondary outcome was OS of patients with only T2N0M0 MIBC.<h4>Results</h4>Eight studies were included in this meta-analysis. Overall, the quality of all studies was relatively high, and little publication bias was demonstrated. The OS was significantly better in the NAC with RC group than in RC alone (HR, 0.79; 95% CI, 0.68-0.92; p = 0.002). A subgroup analysis was performed on only patients with T2N0M0 MIBC, and five studies were included. There was no difference in the OS between the NAC with RC and the RC alone groups (HR, 0.83; 95% CI, 0.69-1.01 p = 0.06).<h4>Conclusions</h4>As recommended by the EAU guidelines Rapid Reaction Group, patients with T2N0M0 MIBC should strongly consider omitting NAC until the end of the COVID-19 pandemic. Whether to omit NAC in T3-4aN0M0 MIBC needs further discussion, and studies targeting only T2-3N0M0 MIBC are expected to proceed further.https://doi.org/10.1371/journal.pone.0267410 |
| spellingShingle | Dong Hyuk Kang Kang Su Cho Young Joon Moon Doo Yong Chung Hae Do Jung Joo Yong Lee Effect of neoadjuvant chemotherapy on overall survival of patients with T2-4aN0M0 bladder cancer: A systematic review and meta-analysis according to EAU COVID-19 recommendation. PLoS ONE |
| title | Effect of neoadjuvant chemotherapy on overall survival of patients with T2-4aN0M0 bladder cancer: A systematic review and meta-analysis according to EAU COVID-19 recommendation. |
| title_full | Effect of neoadjuvant chemotherapy on overall survival of patients with T2-4aN0M0 bladder cancer: A systematic review and meta-analysis according to EAU COVID-19 recommendation. |
| title_fullStr | Effect of neoadjuvant chemotherapy on overall survival of patients with T2-4aN0M0 bladder cancer: A systematic review and meta-analysis according to EAU COVID-19 recommendation. |
| title_full_unstemmed | Effect of neoadjuvant chemotherapy on overall survival of patients with T2-4aN0M0 bladder cancer: A systematic review and meta-analysis according to EAU COVID-19 recommendation. |
| title_short | Effect of neoadjuvant chemotherapy on overall survival of patients with T2-4aN0M0 bladder cancer: A systematic review and meta-analysis according to EAU COVID-19 recommendation. |
| title_sort | effect of neoadjuvant chemotherapy on overall survival of patients with t2 4an0m0 bladder cancer a systematic review and meta analysis according to eau covid 19 recommendation |
| url | https://doi.org/10.1371/journal.pone.0267410 |
| work_keys_str_mv | AT donghyukkang effectofneoadjuvantchemotherapyonoverallsurvivalofpatientswitht24an0m0bladdercancerasystematicreviewandmetaanalysisaccordingtoeaucovid19recommendation AT kangsucho effectofneoadjuvantchemotherapyonoverallsurvivalofpatientswitht24an0m0bladdercancerasystematicreviewandmetaanalysisaccordingtoeaucovid19recommendation AT youngjoonmoon effectofneoadjuvantchemotherapyonoverallsurvivalofpatientswitht24an0m0bladdercancerasystematicreviewandmetaanalysisaccordingtoeaucovid19recommendation AT dooyongchung effectofneoadjuvantchemotherapyonoverallsurvivalofpatientswitht24an0m0bladdercancerasystematicreviewandmetaanalysisaccordingtoeaucovid19recommendation AT haedojung effectofneoadjuvantchemotherapyonoverallsurvivalofpatientswitht24an0m0bladdercancerasystematicreviewandmetaanalysisaccordingtoeaucovid19recommendation AT jooyonglee effectofneoadjuvantchemotherapyonoverallsurvivalofpatientswitht24an0m0bladdercancerasystematicreviewandmetaanalysisaccordingtoeaucovid19recommendation |